Clinical and instrumental characteristics of coronary heart disease in association with type 2 diabetes mellitus
Abstract
Aim. To study the clinical and instrumental characteristics of the course of coronary heart disease in association with type 2 diabetes mellitus.
Material and research methods. The material for the study was 116 patients with coronary heart disease who met the selection criteria. All patients depending on the presence of diabetes mellitus were divided into two groups: group I with type 2 diabetes mellitus (n=44) and group II without type 2 diabetes mellitus (n=72).
Research results. Patients with coronary heart disease in association with type 2 diabetes mellitus were older and accounted for 37.9% of the total group. Among the risk factors, arterial hypertension, hypercholesterolemia and obesity occupied leading positions in the compared groups. An analysis of the course of coronary heart disease in the compared groups showed that nonanginal or other symptoms (shortness of breath) were more often observed in diabetics. According to the results of echocardiography, the size of the atria (left and right) was higher in the group of patients with diabetes.
Conclusions. The study showed that patients with coronary heart disease in association with type 2 diabetes were older, had a higher body mass index and cardiovascular risk factors.
About the Author
I. B. Gairatova
State Institution «Tajik Research Institute of Preventive Medicine»;
State Institution «Republican Clinical Center of Cardiology» MH SZN RT
Tajikistan
Tajikistan
References
1. Vorozhtsova I.N. Vliyaniye sakharnogo diabeta 2-go typa na miokard patsientov s ishemicheskoy bolezni serdsa [Effect of type 2 diabetes mellitus on the myocardium of patients with coronary heart disease] / I.N. Vorozhtsova, O.V. Budnikova, S.A. Afanasiev, D.S. Kondratieva// Sibirskiy medicinskiy jurnal Siberian Medical Journal. – 2018. – 33(1). R. 14-20.
2. Mardanov B.U. Osobennosti klinico-gemodinamichnikh parametrov I koronarnogo krovooka bolnikh s ishemicheskoy bolezni serdsa [Features of clinical and hemodynamic parameters and coronary blood flow in patients with chronic coronary heart disease and type 2 diabetes mellitus] /B.U. Mardanov, M.A. Kokozheva, F.B. Shukurov et al. // Rossiyskiy kardiologicheskiy jurnal Russian Journal of Cardiology. 2021. No. 26 (12). R.39-46.
3. Shukurova S.M. Diabeticheskaya nephropatiya: sovremenniye voprosi diagnostiki I terapii [Diabetic nephropathy: current issues of diagnosis and therapy] /S.M. Shukurova, I.M. Rashidov, S.J. Kosimova, A.I. Faizulloev//J. «Medisinskiy vestnik Natsionalnoy akademii nauk tadjikistana» J. “Medical Bulletin of the National Academy of Sciences of Tajikistan”. Dushanbe. 2021 No. 1. P.55-61.
4. Cai X. Association Between Prediabetes and Risk of All-Cause Mortality and Cardiovascular Disease: Updated Meta-Analysis /X. Cai, Y. Zhang, M. Li, et al. // Bmj. 2020. №370. Р. 92-97.
5. Das S.R. Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee /S.R. Das, B.M. Everett, K.K. Birtcher, et al. //J Am Coll Cardiol. 2020 Sep 1. No76(9). – P.1117-1145.
6. Liu B. Genetically Predicted Type 2 Diabetes Mellitus Liability, Glycated Hemoglobin and Cardiovascular Diseases: A Wide-Angled Mendelian Randomization Study /B. Liu, A.M. Mason, L. Sun, et al.//Genes (Basel). – 2021. No12(10). – P.1644.
7. Sattar N. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks /N. Sattar, A. Rawshani, S. Franzen, et al. //Circulation. 2019. No139. Р. 2228-2237.
8. Wright A.K. Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes /A.K. Wright, M.J. Carr, E. Kontopantelis, et al. //Diabetes Care. 2022 Apr 1. No45(4). – P. 909-918.
Review
For citations:
Gairatova I.B. Clinical and instrumental characteristics of coronary heart disease in association with type 2 diabetes mellitus. Herald of the medical and social institute of Tajikistan. 2023;(3):12-21. (In Russ.)
Views:
40
Email this article 